Alethus

Curated by Signal

Non-invasive glucose monitoring systems based on Mid-Infrared Spectroscopy

Overview

Non-invasive glucose monitoring systems based on Mid-Infrared Spectroscopy. It allows diabetic patients to measure their glucose levels multiple times. It does not require the users to prick their fingers to conduct the tests.

Key facts

Founded: 2009
Headquarters: Boston, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

4 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

149Medical
Developer of non-invasive monitors for pediatric use
Life Sciences TechnologyCambridge, United States
Mirvie
Provider of non-invasive diagnostic tests for pregnant women
Life Sciences TechnologySan Francisco, United States
Atavistik
Developer of allosteric therapeutics for precision oncology and rare diseases
Life Sciences TechnologyCambridge, United States

About Alethus

What does Alethus do?

Non-invasive glucose monitoring systems based on Mid-Infrared Spectroscopy.

Where is Alethus headquartered?

Alethus is headquartered in Boston, United States.

When was Alethus founded?

Alethus was founded in 2009.

Which sector is Alethus in?

Alethus operates in Life Sciences Technology.

Who are Alethus's competitors?

Companies similar to Alethus include 149Medical, Mirvie, and Atavistik.